Atlas Trials

YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone Therapy

Clinical trial NCT00048659 · TERMINATED

Trial details

NCT number
NCT00048659
Sponsor
Astellas Pharma Inc
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Hormone-Refractory Prostate CancerProstatic Neoplasms

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.